STINGing Antitumor Immunity into Action
- PMID: 29371226
- DOI: 10.1158/2159-8290.CD-ND2018-002
STINGing Antitumor Immunity into Action
Abstract
Efforts to stimulate STING signaling, thereby turning immunologically "cold" tumors "hot" and receptive to immunotherapy, are gaining ground in the industry. To date, directly targeting the STING receptor with synthetic ligands is the main approach to have entered clinical trials, but indirect small-molecule modulators of the pathway are also being pursued.
©2018 American Association for Cancer Research.
Comment on
-
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.Immunity. 2014 Nov 20;41(5):830-42. doi: 10.1016/j.immuni.2014.10.017. Epub 2014 Nov 5. Immunity. 2014. PMID: 25517615 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
